Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2021
Jeffrey Ishizuka, MD, DPhil
Defining and Overcoming Hypoxic Immune Dysfunction in Head and Neck Cancer
Read More
2021
Matthew Hangauer, PhD
Immunotherapy-Tolerant Cancer Persister Cells
Read More
2021
Christopher Halbrook, PhD
Overcoming Metabolic Heterogeneity to Target Pancreatic Cancer
Read More
2021
Berkley Gryder, PhD
3D Dependencies of Rhabdomyosarcomas Driven by a MYC-mimicking Mutation in MYOD1
Read More
2021
Adam Courtney, PhD
Modulating JAK-STAT signaling in cancer
Read More
2021
Timothy Cragin Wang, MD
Targeting myeloid cells to enhance immune checkpoint blockade in gastric cancer
Read More
2021
Nina Salama, PhD
The oral commensal bacterium Fusobacterium nucleatum as a potential driver of gastric...
Read More
2021
Shivani Srivastava, PhD
Overcoming mechanisms of resistance to AP-1 engineered CAR-T cell therapy *The Translational...
Read More
2021
Steven Reiner, MD
Predictive Biomarkers for Immunotherapy through the Lens of T-cell Regeneration *The Translational...
Read More
2021
Scott Hiebert, PhD
Toward precision therapy for PAX3-FOXO1-dependent rhabdomyosarcoma
Read More
2021
Irene Ghobrial, MD
Defining The Role of The Immune Microenvironment in Precursor Multiple Myeloma
Read More
2021
Robert Canter, MD
Combining IL-15 with TIGIT Blockade to Stimulate Natural Killer Anti-Tumor Immunity in...
Read More
2021
Tannishtha Reya, PhD
Developing antibody-based therapies for myeloid leukemia
Read More
2021
Justin P. Kline, MD
Immunotherapeutic targeting of macrophages in diffuse large B cell lymphoma
Read More
2021
Adilia Hormigo, MD, PhD
Host tissue determinants of immunity and clinical response in glioblastoma
Read More
2021
J. Silvio Gutkind, PhD
Precision immune-oncology therapy targeting HER3-PI3K/mTOR and PD-1 in HNSCC
Read More